ProfileGDS4718 / 213246_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 89% 85% 87% 89% 84% 89% 89% 91% 91% 88% 89% 88% 85% 81% 91% 93% 90% 86% 80% 89% 89% 91% 91% 85% 88% 92% 80% 87% 77% 84% 80% 86% 91% 88% 88% 87% 89% 89% 86% 90% 86% 86% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9751988
GSM549102patient 115, normal, homogenized [OPG study]8.9304689
GSM549104patient 119, normal, homogenized [OPG study]8.5720485
GSM549108patient 138, normal, homogenized [OPG study]8.7026487
GSM549119patient 077, normal, homogenized [OPG study]9.0646789
GSM549133patient 032, cancer, homogenized [OPG study]8.4609484
GSM549139patient 042, cancer, homogenized [OPG study]8.9855289
GSM549099patient 107, normal, homogenized [OPG study]9.0357889
GSM549109patient 139, normal, homogenized [OPG study]9.3441991
GSM549110patient 046, normal, homogenized [OPG study]9.3447291
GSM549114patient 063, normal, homogenized [OPG study]9.0807288
GSM549122patient 082, normal, homogenized [OPG study]8.9913789
GSM549134patient 033, cancer, homogenized [OPG study]8.9669888
GSM549136patient 036, cancer, homogenized [OPG study]8.564785
GSM549140patient 044, cancer, homogenized [OPG study]8.1092781
GSM549111patient 047, normal, homogenized [OPG study]9.4200391
GSM549113patient 057, normal, homogenized [OPG study]9.9019293
GSM549132patient 031, cancer, homogenized [OPG study]9.1148390
GSM549137patient 038, cancer, homogenized [OPG study]8.6191286
GSM549142patient 047, cancer, homogenized [OPG study]7.6305180
GSM549100patient 110, normal, homogenized [OPG study]8.9269489
GSM549107patient 135, normal, homogenized [OPG study]9.0929989
GSM549115patient 068, normal, homogenized [OPG study]9.6075291
GSM549116patient 072, normal, homogenized [OPG study]9.5313991
GSM549120patient 078, normal, homogenized [OPG study]8.4630885
GSM549131patient 030, cancer, homogenized [OPG study]8.9640788
GSM549118patient 074, normal, homogenized [OPG study]9.5868992
GSM549129patient 027, cancer, homogenized [OPG study]7.9320180
GSM549123patient 088, normal, homogenized [OPG study]8.7778387
GSM549124patient 006, cancer, homogenized [OPG study]7.4648377
GSM549126patient 015, cancer, homogenized [OPG study]8.2763184
GSM549128patient 025, cancer, homogenized [OPG study]7.898180
GSM549103patient 117, normal, homogenized [OPG study]8.4611586
GSM549117patient 073, normal, homogenized [OPG study]9.5534591
GSM549138patient 041, cancer, homogenized [OPG study]8.939888
GSM549141patient 045, cancer, homogenized [OPG study]8.9403688
GSM549130patient 028, cancer, homogenized [OPG study]8.7098987
GSM549101patient 111, normal, homogenized [OPG study]9.0035189
GSM549105patient 128, normal, homogenized [OPG study]8.9251189
GSM549106patient 134, normal, homogenized [OPG study]8.8061586
GSM549112patient 048, normal, homogenized [OPG study]9.2078890
GSM549125patient 011, cancer, homogenized [OPG study]8.5901986
GSM549127patient 024, cancer, homogenized [OPG study]8.6040686
GSM549135patient 035, cancer, homogenized [OPG study]9.2459790